Compare CLMB & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLMB | TECX |
|---|---|---|
| Founded | 1982 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 527.7M | 618.9M |
| IPO Year | 1996 | 2018 |
| Metric | CLMB | TECX |
|---|---|---|
| Price | $28.33 | $29.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $80.00 | $75.20 |
| AVG Volume (30 Days) | 115.7K | ★ 197.6K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | 14.29 | ★ 40.70 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $652,517,000.00 | N/A |
| Revenue This Year | $7.82 | N/A |
| Revenue Next Year | $5.83 | N/A |
| P/E Ratio | $57.29 | ★ N/A |
| Revenue Growth | ★ 40.14 | N/A |
| 52 Week Low | $15.25 | $14.39 |
| 52 Week High | $145.00 | $39.53 |
| Indicator | CLMB | TECX |
|---|---|---|
| Relative Strength Index (RSI) | 50.46 | 41.97 |
| Support Level | $26.50 | $27.53 |
| Resistance Level | $29.14 | $31.39 |
| Average True Range (ATR) | 1.11 | 2.18 |
| MACD | -0.18 | -0.61 |
| Stochastic Oscillator | 41.15 | 10.57 |
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.